Last mentioned: Mar 18, 2026
Expansion Target
Goal to reach 130 active sales territories by fiscal year-end
Earnings Release
Announced 63% revenue growth and VA hospital network access
Report Release
Official data is released confirming the rise in NY veteran suicide deaths for the 2023 period.
Q3 Fiscal End
Closed third quarter with 100 active sales territories
Equity Offering
Completed capital raise to bolster cash position to $291M
VA Mission Daybreak
The VA launches new grant programs to accelerate innovative suicide prevention solutions.
Reporting Period Ends
The calendar year 2023 concludes, later identified as a period of increased veteran suicides.
Dwyer Project Expansion
New York State expands the Joseph P. Dwyer Peer Support Project to cover all 62 counties.
Kestra Medical (KMTS) delivered a strong Q3 2026 performance, highlighted by a 63% year-over-year revenue increase and the ninth consecutive quarter of gross margin expansion. While net losses widened to $34.2 million due to aggressive sales force expansion, the company secured critical access to the VA Federal Supply Schedule and expanded its Florida Medicaid footprint.
Kestra Medical reported a 63% year-over-year revenue increase to $24.6 million in Q3 2026, driven by record prescriptions for its Assure wearable cardioverter defibrillator. The company significantly expanded its market access through a new U.S. Department of Veterans Affairs contract and improved Medicaid coverage in Florida.
Kestra Medical (KMTS) delivered a robust Q3 2026 with $24.6 million in revenue, driven by a 58% surge in Assure system prescriptions. Despite a widening net loss of $34.2 million, the company secured critical access to the VA Federal Supply Schedule and expanded its Florida Medicaid footprint.
A new report reveals an increase in veteran suicide deaths in New York for 2023, reversing recent progress in prevention efforts. The data has sparked urgent calls for expanded mental health resources and better integration between state and federal support systems.